Telomeres and the ageing process

Reviews in Clinical Gerontology

Volumn 20, Issue 1, 2010, Pages 1-9

  Woo, Jean ^a   Suen, Eddie ^a   Tang, Nelson L S ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

ageing; chronic disease; frailty; lifespan; telomeres

Indexed keywords

ATORVASTATIN; BIOLOGICAL MARKER; CYTOKINE; HEAT SHOCK PROTEIN; LEPTIN; TELOMERASE;

AGING; ALZHEIMER DISEASE; ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; BLADDER CANCER; BODY MASS; BONE DENSITY; BONE TURNOVER; BREAST CANCER; CANCER INHIBITION; CARCINOGENESIS; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME SIZE; CHRONIC DISEASE; CHRONIC INFLAMMATION; CORONARY ARTERY DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; ENVIRONMENT; GENETIC REGULATION; GENOMIC INSTABILITY; GEOGRAPHICAL VARIATION (SPECIES); HEART DISEASE; HUMAN; INFECTION; LEUKOCYTE; LIFESTYLE; LUNG CANCER; MENTAL STRESS; METHODOLOGY; MILD COGNITIVE IMPAIRMENT; MITOCHONDRIAL DNA DEPLETION; OBESITY; OSTEOLYSIS; OSTEOPOROSIS; OXIDATIVE STRESS; PHENOTYPE; PHYSICAL ACTIVITY; PROTO ONCOGENE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SKIN CANCER; SMOKING; SOCIAL STATUS; TELOMERE; TUMOR SUPPRESSOR GENE; VIRUS INFECTION;

EID: 76549118059     PISSN: 09592598     EISSN: 14699036     Source Type: Journal    
DOI: 10.1017/S0959259809990451     Document Type: Review

References (94)

1. Blackburn EH. Switching and signaling at the telomere. Cell 2001; 106: 661-73.
2. Liu D, O'Connor MS, Qin J, Songyang Z. Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J Biol Chem 2004; 279: 51338-42.
3. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19: 2100-10.
4. Blackburn EH, Chan S, Chang J et al. Molecular manifestations and molecular determinants of telomere capping. Cold Spring Harb Symp Quant Biol 2000; 65: 253-63.
5. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37: 614-36.
6. Greider CW, Blackburn EH. Tracking telomerase. Cell 2004; 116 (suppl) : S83-6.
7. von Zglinicki T, Saretzki G, Docke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 1995; 220: 186-93.
8. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339-44.
9. Carrero JJ, Stenvinkel P, Fellstrom B et al. Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J Intern Med 2008; 263: 302-12.
10. Frenck RW Jr, Blackburn EH, Shannon KM. The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci USA 1998; 95: 5607-10.
11. Benetos A, Okuda K, Lajemi M et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 2001; 37: 381-85.
12. Jeanclos E, Schork NJ, Kyvik KO, Kimura M, Skurnick JH, Aviv A. Telomere length inversely correlates with pulse pressure and is highly familial. Hypertension 2000; 36: 195-200.
13. Nawrot TS, Staessen JA, Gardner JP, Aviv A. Telomere length and possible link to X chromosome. Lancet 2004; 363: 507-10.
14. Okuda K, Bardeguez A, Gardner JP et al. Telomere length in the newborn. Pediatr Res 2002; 52: 377-81.
15. Bayne S, Liu JP. Hormones and growth factors regulate telomerase activity in ageing and cancer. Mol Cell Endocrinol 2005; 240: 11-22.
16. Aviv A. Telomeres and human somatic fitness. J Gerontol A Biol Sci Med Sci 2006; 61: 871-73.
17. Baba T, Shimizu T, Suzuki Y et al. Estrogen, insulin, and dietary signals cooperatively regulate longevity signals to enhance resistance to oxidative stress in mice. J Biol Chem 2005; 280: 16417-26.
18. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002; 23: 90-119.
19. Vina J, Borras C, Gambini J, Sastre J, Pallardo FV. Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett 2005; 579: 2541-45.
20. Monaghan P, Haussmann MF. Do telomere dynamics link lifestyle and lifespan? Trends Ecol Evol 2006; 21: 47-53.
21. Johnson TE. Recent results: biomarkers of aging. Exp Gerontol 2006; 41: 1243-6.
22. Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol 1998; 16: 743-47.
23. Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146-56.
24. Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci 2007; 62: 722-27.
25. Hayflick L. Living forever and dying in the attempt. Exp Gerontol 2003; 38: 1231-41.
26. Zeichner SL, Palumbo P, Feng Y et al. Rapid telomere shortening in children. Blood 1999; 93: 2824-30.
27. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003; 361: 393-95.
28. Woo J, Tang N, Leung J. No association between physical activity and telomere length in an elderly Chinese population 65 years and older. Archives of Internal Medicine 2008; 168: 2163-64.
29. Martin-Ruiz CM, Haroutunian VH, Long P et al. Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia. Biol Psychiatry 2003; 54: 1222-33.
30. Bischoff C, Petersen HC, Graakjaer J et al. No association between telomere length and survival among the elderly and oldest old. Epidemiology 2006; 17: 190-94.
31. Aviv A, Valdes AM, Spector TD. Human telomere biology: pitfalls of moving from the laboratory to epidemiology. Int J Epidemiol 2006; 35: 1424-29.
32. Klemera P, Doubal S. A new approach to the concept and computation of biological age. Mech Ageing Dev 2006; 127: 240-48.
33. Demerath EW, Cameron N, Gillman MW, Towne B, Siervogel RM. Telomeres and telomerase in the fetal origins of cardiovascular disease: a review. Hum Biol 2004; 76: 127-46.
34. Benetos A, Gardner JP, Zureik M et al. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension 2004; 43: 182-85.
35. Brouilette SW, Moore JS, McMahon AD et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 2007; 369: 107-14.
36. Epel ES, Lin J, Wilhelm FH et al. Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology 2006; 31: 277-87.
37. Fitzpatrick AL, Kronmal RA, Gardner JP et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol 2007; 165: 14-21.
38. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. Lancet 2001; 358: 472-73.
39. Starr JM, McGurn B, Harris SE, Whalley LJ, Deary IJ, Shiels PG. Association between telomere length and heart disease in a narrow age cohort of older people. Exp Gerontol 2007; 42: 571-73.
40. van der Harst P, van der Steege G, de Boer RA et al. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol 2007; 49: 1459-64.
41. Kotur-Stevuljevic J, Memon L, Stefanovic A et al. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem 2007; 40: 181-87.
42. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
43. Thomas MK, Narang D, Lakshmy R, Gupta R, Naik N, Maulik SK. Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients 'on' and 'off' atorvastatin for short time intervals. Cardiovasc Drugs Ther 2006; 20: 37-44.
44. Gorenne I, Melli M, John M, Mathews C, Goddard M, Bennett M. Vascular smooth muscle cell senescence and telomere attrition in atheroscleroses. Abstract presented at the XIX IAGG World Congress of Gerontology and Geriatrics; July 2009, Paris, France.
45. Woo J, Tang NLS, Suen E, Leung J. Shorter telomere length is associated with greater decrease in ankle-brachial index in elderly Chinese women but not men. J Human Hypertension (submitted) 2009.
46. Shay JW, Wright WE. Hallmarks of telomeres in ageing research. J Pathol 2007; 211: 114-23.
47. Gilley D, Tanaka H, Herbert BS. Telomere dysfunction in aging and cancer. Int J Biochem Cell Biol 2005; 37: 1000-13.
48. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120: 513-22.
49. Broberg K, Bjork J, Paulsson K, Hoglund M, Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005; 26: 1263-71.
50. Han J, Qureshi AA, Prescott J et al. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol 2009; 129: 415-21.
51. Jang JS, Choi YY, Lee WK et al. Telomere length and the risk of lung cancer. Cancer Sci 2008; 99: 1385-89.
52. Svenson U, Nordfjall K, Stegmayr B et al. Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res 2008; 68: 3618-23.
53. Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A. Human immunosenescence: is it infectious? Immunol Rev 2005; 205: 257-68.
54. Vallejo AN, Weyand CM, Goronzy JJ. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med 2004; 10: 119-24.
55. Aikata H, Takaishi H, Kawakami Y et al. Telomere reduction in human liver tissues with age and chronic inflammation. Exp Cell Res 2000; 256: 578-82.
56. Sekoguchi S, Nakajima T, Moriguchi M et al. Role of cell-cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C. J Gastroenterol Hepatol 2007; 22: 182-90.
57. Wiemann SU, Satyanarayana A, Tsahuridu M et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J 2002; 16: 935-42.
58. Ilmonen P, Kotrschal A, Penn DJ. Telomere attrition due to infection. PLoS One 2008; 3: e2143.
59. Bekaert S, Van Pottelbergh I, De Meyer T et al. Telomere length versus hormonal and bone mineral status in healthy elderly men. Mech Ageing Dev 2005; 126: 1115-22.
60. Valdes AM, Richards JB, Gardner JP et al. Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis. Osteoporos Int 2007; 18: 1203-10.
61. Tang NL, Woo J, Suen EW, Liao CD, Leung JC, Leung PC. The effect of telomere length, a marker of biological aging, on bone mineral density in elderly population. Osteoporos Int 2009. 2010; 21: 89-97.
62. Grodstein F, van Oijen M, Irizarry MC et al. Shorter telomeres may mark early risk of dementia: preliminary analysis of 62 participants from the nurses' health study. PLoS One 2008; 3: e1590.
63. Martin-Ruiz C, Dickinson HO, Keys B, Rowan E, Kenny RA, Von Zglinicki T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol 2006; 60: 174-80.
64. Panossian LA, Porter VR, Valenzuela HF et al. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 2003; 24: 77-84.
65. Honig LS, Schupf N, Lee JH, Tang MX, Mayeux R. Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann Neurol 2006; 60: 181-87.
66. Guan JZ, Maeda T, Sugano M et al. A percentage analysis of the telomere length in Parkinson's disease patients. J Gerontol A Biol Sci Med Sci 2008; 63: 467-73.
67. Wang H, Chen H, Gao X et al. Telomere length and risk of Parkinson's disease. Mov Disord 2008; 23: 302-5.
68. Gao HM, Liu B, Zhang W, Hong JS. Novel anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol Sci 2003; 24: 395-401.
69. Petrozzi L, Lucetti C, Gambaccini G et al. Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients. Neurol Sci 2001; 22: 83-84. (Pubitemid 33622093)
70. Campbell AJ, Buchner DM. Unstable disability and the fluctuations of frailty. Age Ageing 1997; 26: 315-18.
71. Markle-Reid M, Browne G. Conceptualizations of frailty in relation to older adults. J Adv Nurs 2003; 44: 58-68.
72. Rockwood K, Fox RA, Stolee P, Robertson D, Beattie BL. Frailty in elderly people: an evolving concept. CMAJ 1994; 150: 489-95.
73. Mitnitski AB, Graham JE, Mogilner AJ, Rockwood K. Frailty, fitness and late-life mortality in relation to chronological and biological age. BMC Geriatr 2002; 2: 1.
74. Walston J. Frailty - the search for underlying causes. Sci Aging Knowledge Environ 2004; 4: pe4.
75. Rodier F, Kim SH, Nijjar T, Yaswen P, Campisi J. Cancer and aging: the importance of telomeres in genome maintenance. Int J Biochem Cell Biol 2005; 37: 977-90.
76. Wu IC, Shiesh SC, Kuo PH, Lin XZ. High oxidative stress is correlated with frailty in elderly Chinese. J Am Geriatr Soc 2009; 57: 1666-71.
77. Woo J, Tang NL, Suen E, Leung JC, Leung PC. Telomeres and frailty. Mech Ageing Dev 2008; 129: 642-48.
78. Valdes AM, Andrew T, Gardner JP et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662-64.
79. Nettleton JA, Diez-Roux A, Jenny NS, Fitzpatrick AL, Jacobs DR Jr. Dietary patterns, food groups, and telomere length in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2008; 88: 1405-12.
80. Chan R, Woo J, Suen E, Leung J, Tang N. Chinese tea consumption is associated with longer telomere length in elderly Chinese men. Br J Nutr 2010; 103: 107-13.
81. Cherkas LF, Hunkin JL, Kato BS et al. The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med 2008; 168: 154-58.
82. Irie M, Asami S, Ikeda M, Kasai H. Depressive state relates to female oxidative DNA damage via neutrophil activation. Biochem Biophys Res Commun 2003; 311: 1014-18.
83. Epel ES, Blackburn EH, Lin J et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004; 101: 17312-15.
84. Adams JM, White M. Biological ageing: a fundamental, biological link between socio-economic status and health? Eur J Public Health 2004; 14: 331-34.
85. Marmot M. Social determinants of health inequalities. Lancet 2005; 365: 1099-104.
86. Cherkas LF, Aviv A, Valdes AM et al. The effects of social status on biological aging as measured by white-blood-cell telomere length. Aging Cell 2006; 5: 361-65.
87. Woo J, Suen EW, Leung JC, Tang NL, Ebrahim S. Older men with higher self-rated socioeconomic status have shorter telomeres. Age Ageing 2009; 38: 553-58.
88. Hartig T. Green space, psychological restoration, and health inequality. Lancet 2008; 372: 1614-15.
89. Woo J, Tang N, Suen E, Leung J, Wong M. Green space, psychological restoration, and telomere length. Lancet 2009; 373: 299-300.
90. Canela A, Klatt P, Blasco MA. Telomere length analysis. Methods Mol Biol 2007; 371: 45-72.
91. Baird DM. New developments in telomere length analysis. Exp Gerontol 2005; 40: 363-68.
92. Wong JM, Collins K. Telomere maintenance and disease. Lancet 2003; 362: 983-88.
93. Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 2005; 6: 611-22.
94. Zhang P, Dilley C, Mattson MP. DNA damage responses in neural cells: Focus on the telomere. Neuroscience 2007; 145: 1439-48.